GlassScriptPhysician profile
Charles Robert Diard
NPI 1598342669
$2,998.44
in general payments reported to CMS, 2019-2025
7 companies · $1,025 in 2025
The $1,025 reported for 2025 was more than what 85% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $694 · 2024: $1,279 · 2025: $1,025.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,998.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,998.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,176.57 | 2023-2025 | Indigo System, Ruby Coil, Penumbra System |
| Medtronic, INC. | $315.81 | 2024-2025 | Emprint |
| Boston Scientific Corporation | $159.01 | 2023 | Wallflex Biliary Transhepatic, Therasphere Y90 Glass Microspheres 10 Gbq |
| Stryker Corporation | $134.55 | 2025 | Clottriever Bold Catheter |
| Recor Medical INC | $117.88 | 2024 | Paradise Renal Denervation System |
| Astrazeneca Pharmaceuticals LP | $58.02 | 2023 | |
| Route 92 Medical, INC. | $36.60 | 2023 | 8f Base Camp Sheath System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Diard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.